Podcasts about rutgers

Week 7 rolls on—20 more games, all numbers, no fluff. I'm back to trusting the models over narratives and hunting edges you can actually bet.We hit every corner of the slate: Missouri State–MTSU, ECU–Tulane, Southern Miss–Georgia Southern, Rutgers–Washington (Friday), Florida State–Pitt, Washington State–Ole Miss, Wake Forest–Oregon State, Nebraska–Maryland, Northwestern–Penn State, Old Dominion–Marshall, Virginia Tech–Georgia Tech, Florida–Texas A&M, NC State–Notre Dame, Iowa State–Colorado, Arkansas–Tennessee, Iowa–Wisconsin, BYU–Arizona, New Mexico–Boise State, Utah State–Hawaiʻi, and UCF–Cincinnati. We'll lean on success rate, PPA margin, havoc, five-factors, and red-zone finishing to separate real value from brand tax.1:00 Missouri State vs Middle Tennessee3:24 East Carolina vs Tulane5:39 Southern Miss vs Georgia Southern8:29 Rutgers vs Washington12:43 Pitt vs Florida State16:21 Washington State vs Ole Miss19:59 Wake Forest vs Oregon State23:13 Nebraska vs Maryland27:13 Northwestern vs Penn State31:24 Old Dominion vs Marshall34:09 Virginia Tech vs Georgia Tech37:00 Florida vs Texas A&M42:05 NC State vs Notre Dame45:21 Iowa State vs Colorado49:28 Arkansas vs Tennessee54:03 Iowa vs Wisconsin57:48 BYU vs Arizona1:01:03 New Mexico vs Boise State1:05:26 Utah State vs Hawaii1:08:24 UCF vs Cincinnati

Big games on Thursday and Friday night, the Big 12 race stays tight and a rare but needed Rutgers appreciation. Sign up for the newsletter and/or browse the merch here: https://linktr.ee/rakesreport

Mike and Richie are joined by Christian Caple, the co-host of the Say Who, Say Pod podcast and the publisher of On Montlake. They discuss everything around the Rutgers/Washington matchup and give their game predictions! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Day nine of the government shutdown and the stalemate is getting messier. Todd breaks down why Senate Democrats keep blocking a “clean CR,” what that really means, and why Trump's talk of federal reductions-in-force is suddenly on the table. Then we turn to campus speech wars: a Change.org petition targets the Turning Point USA chapter at Rutgers, accusing it of “hate speech”—Todd explains what's actually at stake and shares a personal story about hearts changing after Charlie Kirk's assassination. Finally, California Rep. Katie Porter melts down in a local TV interview, bristling at basic follow-ups while running for governor.Conservative… not bitter, with clarity, context, and a few laughs along the way.(Sponsor) Full Suite Wealth → https://fullsuitewealth.com

Brock discusses UW's comeback victory and upcoming game with Rutgers in Washington Wednesday. Then, Adam Wainwright is on the call for FOX for the ALDS and he joins us to discuss the "dynamic" Seattle offense, what has stood out to about the M's so far, Bryce Millers' confidence heading into game four, how impressed he was with the M's fans in Seattle and what they keys are for the M's to win the series today. Plus, Salk crowns a Trash Takes winner for the week.

Husky Honks! Mario Bailey and Greg Lewis join to give a breakdown of the comeback win over Maryland and what we can expect as they take on Rutgers this weekend. The guys continue on to discuss the state of the Huskies and where they are in their season. We wrap things up with the Honks.See omnystudio.com/listener for privacy information.

Jessica Coody is joined in studio by Kelly Natter for this week's episode of "The Dig," Kelly recaps the Huskers' dominate performance over #16 Penn State, what went into one of the best defensive performances in program history, why block numbers are down this season, Kelly talks the record crowd and sweep over Rutgers, the play of freshman middle Manaia Ogbechie, how setter Bergen Reilly is improved this season, breaking down film with the liberos, her biggest coaching influences growing up, Kelly previews Washington and Purdue and more!

Scott and James are back, and they're bringingthe heat (and probably a few bad bets). They're making money, baby, up to 35-25 on the year! The Hoosier Hot Streak is so hot it's got four legs this week, so you know a parlay is coming your way. They kick things off with Iowa going to Wisconsin, where theBadgers are three-and-a-half-point underdogs at home. The hosts muse about howone good coach can make (or break) a program. Then, it's on to Purdue vs.Minnesota, where the Gophers are rowing their way to an eight-and-a-half-pointfavorite spot. And who could forget the Michigan vs. USC game? A huge matchup,especially if USC hadn't stumbled against Illinois! The boys then tackle Ohio State vs. Illinois, where theFighting Illini are a whopping 14-and-a-half-point underdog at home. They alsodissect Penn State vs. Northwestern, where the Nittany Lions are a21-and-a-half-point favorite after their "silent" performance againstUCLA. Scott vows to never again take Penn State to cover over three touchdowns. Next up, Nebraska heads to Maryland, where the Terrapins area six-and-a-half-point underdog at home. Then, UCLA, fresh off their big win,goes to Michigan State, where the Spartans are an eight-and-a-half-pointfavorite. The hosts then dive into Rutgers vs. Washington, where the ScarletKnights are a 10-and-a-half-point underdog on the road. Finally, the main event: Indiana vs. Oregon. Game Day isthere, and the Hoosiers are a seven-and-a-half-point underdog. Scott and Jamesgrapple with their IU fandom and their gambling instincts, discussing thepossibility of a Heisman moment for Fernando Mendoza and a Big Ten title gameappearance for the Hoosiers. They also talk about a few future bets, includingan Indiana playoff appearance and an Indiana win over Penn State. Don't miss the Hoosier Hot Streak picks and Keegan's Sliceof the Pie! This episode is packed with picks, laughs, and a whole lot ofIndiana football hope (and a little bit of dread).

Jedd Fisch and the Washington Huskies return home from Maryland with their first B1G Conference win in program history after an epic comeback win over the Terrapins. As is the new weekly tradition, former interns Jack and Luke take to the microphones to share their thoughts. They begin with providing letter grades for Washington's performance in College Park, which was difficult to do given how different the two halves looked.  Next, Jack and Luke pick one player on each side of the ball to have a stand out performance in The Huskies' upcoming Friday night showdown against the Rutgers Scarlet Knights. For last week's contest, their picks included Denzel Boston, Jacob Manu, and Decker DeGraaf - so they may have cracked the prediction code! Next, they will take to their Betting B1G segment, each picking three lines for B1G conference games for the upcoming week. Both Jack and Luke were 2-1 last week; however, Luke still holds the lead with an excellent 10-5 record for the year. Lastly, they share their confidence interval that Washington will improve to 5-1 this weekend. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

The Rutgers Rant is back to preview the Scarlet Knights' meeting with Washington in Seattle on Friday. We do so alongside program legend Eric LeGrand, who shares his prediction for the game and the latest on his business venture that is now collaborating with his alma mater. Read our reporting at NJ.com/Rutgers, join our Discord community (discord.gg/fbVDPPA3uW) to interact with us and other Scarlet Knight fans and follow us on Twitter (@RutgersRant) for the latest updates on the show. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mike is joined by PFF Lead NFL Draft Analyst and co-host of the NFL Stock Exchange podcast Trevor Sikkema to discuss Rutgers' NFL Draft prospects, including Athan Kaliakmanis, Ian Strong, KJ Duff, Antwan Raymond and Eric O'Neill! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On this episode of the SeventySix Capital Sports Leadership Show, Wayne Kimmel interviewed the President & CEO of ANC, Jerry Cifarelli Jr. Although Jerry's father originally founded the company more than 25 years ago, ANCs transformation since Cifarelli re-acquired the company from Learfield in 2023 has been remarkable. Departing from the conventional path of a second-generation, Cifarelli chose to forge his own path, leaving ANC in 2022 after nearly a decade with the firm to establish C10 Media. His strategic acumen and skill as a relationship builder paid dividends immediately when he secured the firm's initial project, designing and installing a cutting-edge multimedia solution for MGM Music Hall at Fenway. In 2023, recognizing a unique opportunity, Cifarelli Jr.. leveraged his long-standing industry relationships and vision for what a re-imagined ANC could be to orchestrate the acquisition of ANC by C10 Media back from Learfield. In less than two years, Jerry has transformed ANC from a digital signage solutions provider into a versatile, full-service technology, advertising, design, and service partner. Following ANC's successful first year, Cifarelli secured a substantial equity partnership in ANC by Fenway Sports Group, ideally positioning the company to fulfill Jerry's vision as a diversified single-source solutions provider and strategic partner, at the epicenter of the sports and entertainment business. Some of its digital signage projects in the past two years include: American Century Field (Milwaukee Brewers); Nationals Field (Washington Nationals); the Toyota Center (Houston Rockets); American Airlines Center (Dallas); Levi's Stadium (SF 49ers); ScotiaBank Arena (Toronto); Gainsbridge FieldHouse (Indiana Pacers); Dodger Stadium; Wells Fargo Center (Philadelphia); Rocket Mortgage Fieldhouse (Cleveland), and Smoothie King Center (New Orleans). And when it comes to college facilities, ANC has relationships with nearly 65% of all colleges, and during the past two years its roster of college sports facility upgrade projects reads like a who's who of college sports: Alabama, Penn State, SMU, Boise State, Marshall, Arkansas, Louisville, Rutgers, West Virginia, Oregon State, South Carolina, and Cal Berkeley.Jerry Cifarelli Jr.:LinkedIn: https://www.linkedin.com/in/jerry-cifarelli/Chapters00:00 Introduction to ANC and Its History02:49 The Evolution of Signage in Sports05:52 ANC's Role in Venue Technology09:08 The Importance of People in the Business12:00 Recognition and Awards in the Industry14:38 Case Studies: Enhancing Fan Experience17:49 Monetizing Sports Venues20:48 The Future of Sports Venues and Technology23:44 The Professionalization of College Sports26:56 Mentorship and Leadership in Sports Business29:44 Advice for Aspiring Sports Professionals

Minnesota Gophers are fresh off a nice win over Rutgers on Saturday. How can the Minnesota Gophers take lessons learn from Rutgers and apply them to Ohio State on Saturday night? If the Minnesota Gophers are to have any chance at a BIG win on Saturday night they'll need a nice night from Koi Perich. Could the 2025 Minnesota Gophers be laying the foundation for a 2026 CFP appearance? Ross Brendel and Thor Nystrom are back for another Gophers 101. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Minnesota Gophers are fresh off a nice win over Rutgers on Saturday. How can the Minnesota Gophers take lessons learn from Rutgers and apply them to Ohio State on Saturday night? If the Minnesota Gophers are to have any chance at a BIG win on Saturday night they'll need a nice night from Koi Perich. Could the 2025 Minnesota Gophers be laying the foundation for a 2026 CFP appearance? Ross Brendel and Thor Nystrom are back for another Gophers 101. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Richie O'Leary and Alec Crouthamel are joined by former Rutgers Football player and entrepreneur Eric LeGrand to talk about his new bourbon collaboration with Rutgers University, offer his thoughts on the 2025 football team and more. 00:00 Introduction and new Scarlet Series LeGrand bourbon 02:39 Rutgers Football Performance Analysis 06:23 Bye Week Strategies and Coaching Adjustments 09:25 Reflections on Coaching Philosophy Changes 11:42 Special Teams and Defensive Line Challenges 15:44 Coaching Staff and Player Development 19:37 Broadcasting Careers of Former Players 21:47 Time Management and Future Plans 23:36 Athletic Director's Impact on Rutgers 24:54 Season Predictions and Fan Expectations 27:01 Personal Recovery Journey and Closing Remarks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ohio State has been impressive overall through the first four games of the season, but there is the feeling that the offense has been holding some things back. Will the Buckeyes open things up against visiting Minnesota this Saturday night? The Golden Gophers are 3-1, but gave up 27 points in a loss at Cal and gave up 28 points in a win over Rutgers. Therefore, this could be an opportunity to cut quarterback Julian Sayin loose and attack deep down the field on a more regular basis. Also, how about this OSU offensive line? It is somehow not getting enough attention. We are doing our small part to change that. That and much more is coming your way on the Monday 5ish. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Buckeye Weekly Podcast: Analyzing Minnesota's Win Over Rutgers & Ohio State's Next ChallengeIn this episode of the Buckeye Weekly Podcast, hosts Tony Gerdeman and Tom Orr discuss the aftermath of Minnesota's 31-28 victory over Rutgers and what it means for their upcoming game against Ohio State. They delve into key performances, such as that of Minnesota's redshirt freshman quarterback Drake Lindsey and his impressive stats. The hosts also examine Minnesota's defensive strengths and weaknesses, focusing on players like Koi Perich and Maverick Baranowski. In addition, they explore the special teams' impact on the game. With insights on how Minnesota's strategies might unfold against Ohio State, Tony and Tom provide a comprehensive preview of the anticipated matchup.00:00 Introduction and Welcome00:10 Recap of the Oregon vs. Penn State Game00:58 Minnesota vs. Rutgers Game Analysis04:27 Minnesota's Offensive Performance12:54 Minnesota's Defensive Performance17:57 Special Teams and Final Thoughts19:17 Closing Remarks and Sign-Off

Mike and Alec are joined by Rutgers fan hall of famer and Barstool personality TJ Hitchings to discuss the 2025 Rutgers football season thus far, the outlook for the rest of the season, the 2024-25 hoops letdown, the direction of the hoops program and much more! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a text message and tell us your thoughts.What if everything we thought we knew about Caribbean literary history was incomplete? That's the premise of today's captivating conversation with Professor Alison Donnell, whose groundbreaking new book, Lost and Found: An A to Z of Neglected Writers of the Anglophone Caribbean (Papillote Press 2025), challenges the traditional narrative that Caribbean literature primarily emerged in the 1950s through male writers who migrated abroad. Through painstaking research spanning decades, Donnell reveals a far richer literary landscape populated by remarkable women writers, Indo-Caribbean voices, and authors who remained within the Caribbean, crafting work specifically for local audiences.The stories behind these recoveries are as fascinating as the writers themselves. We meet Vera Bell, the first female chief clerk of Jamaica's National Water Commission and prolific poet; Monica Skeet, who balanced a conservative teaching career with radical storytelling; and Edwina Melville, the first woman with a tractor license in Guyana who dedicated herself to representing Amerindian life. These weren't just writers – they were teachers, journalists, civil servants, and community leaders whose literary work formed part of a broader mission to build Caribbean cultural literacy.Whether you're a Caribbean literature enthusiast or simply love stories of historical recovery and justice, this episode will transform how you understand the relationship between literature, identity, and cultural memory. Listen now to discover the writers who helped shape Caribbean consciousness long before we knew their names.Alison Donnell is head of Humanities and Professor of Modern Literatures in English at the University of Bristol. She has published widely in the field of Caribbean literature, with significant contributions to the fields of literary history and culture, recovery research of women authors, and Caribbean literary archives. Her recent works reflect her ongoing commitment to exploring and expanding literary histories, including a special double issue of Caribbean Quarterly on Caribbean Literary Archives. Her latest monograph Creolized Sexualities: Undoing Heteronormativity in the literary imagination of the Anglo-Caribbean was published by Rutgers in 2021.Support the showConnect with Strictly Facts - Instagram | Facebook | Twitter | LinkedIn | YouTube | Website Looking to read more about the topics covered in this episode? Subscribe to the newsletter at www.strictlyfactspod.com to get the Strictly Facts Syllabus to your email!Want to Support Strictly Facts? Rate & Leave a Review on your favorite platform Share this episode with someone or online and tag us Send us a DM or voice note to have your thoughts featured on an upcoming episode Donate to help us continue empowering listeners with Caribbean history and education Produced by Breadfruit Media

On this episode of 10KTV Bossman and Jake talk about the Kirill signing, Rocco getting fired, Gophers beating Rutgers, the Ryder Cup, Vikings in Dublin and Winners & Losers

The Go Gopher Podcast with Mike Grimm - Episode #190 features a return visit from Gopher football tight end Jameson Geers, who brings fellow tight end Drew Biber along with him.  We recap the Rutgers win and preview this weekend's game at #1 Ohio State.   From Aquarius Home Services Studio (https://aquariushomeservices.com/)   Sponsored by: (https://www.sunbeltminnesota.com/ & https://www.tnma.com), Affinity Plus Federal Credit Union (https://www.affinityplus.org/gogophers), OnX Maps (https://www.onxmaps.com/), & Cub Foods (www.cubfoods.com)

It's not exactly news that the Nazis didn't like the Jews. But according to the Rutgers historian Jochen Hellbeck, author of World Enemy Number One, the Nazi obsession went so far as to believe that the Soviet Union was owned and operated by a global cabal of Jews. And so, Hellbeck argues, it was not the Western powers but Communist Russia that Nazi Germany viewed as an existential threat—in fact, “World Enemy No. 1.” Jewish revolutionaries, the Nazis believed, had seized power in 1917 and were preparing the Soviet state to destroy Germany and the world. This paranoid delusion drove Nazi Germany's most catastrophic decision: launching Operation Barbarossa in 1941. While Hitler made tactical alliances and fought on multiple fronts, Hellbeck demonstrates through his meticulous archival research that the destruction of “Judeo-Bolshevism” remained the Nazis' primary ideological mission. Drawing on overlooked Soviet sources, including war correspondent Ilya Ehrenburg's writings, Hellbeck shows how this twisted worldview shaped not just propaganda but military strategy, ultimately leading to both the Holocaust and Germany's catastrophic defeat on the Eastern Front.1. The Nazis saw “Judeo-Bolshevism” as one unified threat The Nazis genuinely believed Soviet communism was a Jewish conspiracy for world domination. They conflated Russians, Bolsheviks, and Jews into a single enemy - viewing Karl Marx's Jewish heritage as proof that communism itself was a Jewish plot to destroy Germany.2. This obsession drove Nazi military strategy, not just propaganda Hitler's decision to invade the Soviet Union wasn't merely opportunistic. German military planning for attacking the USSR, including detailed preparations for different rail gauges and propaganda leaflets, began in the mid-1930s - showing this was a long-term ideological priority, not a tactical decision.3. Soviet sources deserve serious historical consideration Western historiography has often dismissed Soviet wartime accounts as propaganda. But Hellbeck's research, particularly examining war correspondent Ilya Ehrenburg's work against German documents, shows these Soviet sources accurately documented Nazi atrocities and mindsets without fabrication.4. Ordinary Germans, not just the SS, committed atrocities The Wehrmacht's brutality on the Eastern Front wasn't limited to special units. Hellbeck found that whenever German soldiers felt threatened, they defaulted to extreme racial violence - a pattern that intensified as the Red Army approached Germany in 1944-45.5. The war's memory continues shaping current conflicts The different ways Eastern and Western Ukraine remembered WWII (Soviet liberation vs. Soviet occupation) contributed to the country's political divisions. Putin's Russia still invokes the “Great Patriotic War” to justify current actions, showing how WWII's contested legacy remains politically explosive.Keen On America is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit keenon.substack.com/subscribe

Austin is joined by Rutgers Head Coach Coquese Washington to talk about the 2025-26 Scarlett Knights. They discuss her additions through the transfer portal, the play of Destiny Adams last season, the "east coast" effect, the Big Ten, and much more. Austin also touches on the JuJu Watkins news off the top, as well as some scheduling notes.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

Chip Scoggins, Ryan Burns and Justin Gaard recap the Gophers back and forth victory over Rutgers and specifically discuss the great effort from quarterback Drake Lindsay to help bring it home. The defense made some great adjustments as the game went on, the guys discuss the Gopher coordinators getting the win over some of their mentors. Anthony Smith looks like a first round pick, safety Kerry Brown had perhaps his best game and Koi Perich bounced back nicely from his struggles at Cal. At the end of the show they recap the weekend in the Big Ten including Oregon/Penn State, Illinois/USC, Indiana/Iowa and do a quick preview of Ohio State. 

Jessica Coody is joined by Jaylen Reyes for this week's episode of "The Dig," Jaylen recaps the first two wins of B1G Conference play, including the positives and areas of improvement, the option of the 6-2 and being interviewed by John Cook, he also dives into what teams try to do to take away the middles, and ways the Huskers can attack when they do, how Virginia Adriano settling in, Jaylen previews the weekend against Penn State and Rutgers and talks a little Husker Football and Dylan Raiola.

The Rutgers Rant is back to recap the Scarlet Knights' loss to Minnesota and look ahead to what they need to fix in the bye week to straighten out their 2025 season outlook. We also share the tragic news of our colleague Todderick Hunt's death while remembering what made him a beloved member of the Rutgers and New Jersey football communities. Read our reporting at NJ.com/Rutgers, join our Discord community (discord.gg/fbVDPPA3uW) to interact with us and other Scarlet Knight fans and follow us on Twitter (@RutgersRant) for the latest updates on the show. Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome back to 'The Jimmy Palumbo Show" Episode 236!! While the Rutgers season seems to be quickly slipping away there is new life within the New York Giants organization! Jimmy & Dave are back to break down Jaxson Dart's first NFL start with the Giants and his WIN over the Chargers! All this and so much more! Enjoy! Like the video and share it to your friends! #Giants #Rutgers #TheJimmyPalumboShow

Ari Meirov's Spotlight Guest Of The Week is 2-time Super Bowl Champion & 11-year NFL veteran Logan Ryan. Logan discusses his path to the NFL, winning 2 Super Bowls with the Patriots, picking off Tom Brady's final pass as a Patriot, being an underdog with the Titans, the intricacies of his contracts in the NFL and how he got into the media with CBS & NFL IQ! 00:00 - Cold open 00:58 - Ari's opening thoughts
 02:30 - Start of interview
 03:32 - Offense or defense?
 04:42 - Playing for Rutgers
 06:30 - Relationship with McCourty twins
 09:32 - Did Bill Belichick find out about the Rutgers guys!?
 10:23- Rookie season
 12:32 - Sign up at FanDuel.com/ARI
 16:40 - Relationship with Darrell Revis
 17:55 - Winning 1st Super Bowl
 19:30 - Winning 2nd Super Bowl
 23:12 - Free agency/Belichick
 30:38 - Relationship with Patriots after leaving
 32:16 - Titans underdog mentality 34:40 - Intercepting Tom Brady's final pass as a Patriot
 38:56 - Long free agency before Giants
 46:00 - Giants/Bucs/49ers tenure
 50:27 - Losing Super Bowl to end career
 53:20 - Joining the media
 54:39 - Who deserves a Spotlight?
 56:37 - Visit Root.com
 01:00:07 - Ari's final thoughts ----------------------------------------------- Sign up for FanDuel Sportsbook today! New customers visit FanDuel.com/ARI & if you win your first $5 wager, you get $300 in bonus bets! ----------------------------------------------- Visit Root.com and find out how you can get rewarded for safe driving with Root Insurance. ----------------------------------------------- NFL Spotlight is dedicated to shining a light on those in the NFL that deserve a spotlight with top-notch insight and research from Ari Meirov. Follow Ari on X: https://x.com/MySportsUpdate Follow Ben on X: https://x.com/BenAllenSports Follow The 33rd Team on X: https://x.com/The33rdTeamFB Learn more about your ad choices. Visit megaphone.fm/adchoices

Mike, Richie and Alec break down what Rutgers needs to do to fix it's issues with consistency on offense, it's issues on special teams and defense and prevent the season from slipping away. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Week 5 in the Big Ten was loaded with drama, and Big Ten Paradigm breaks it all down. Noah Drury recaps Oregon's thrilling double-overtime win at Penn State, Illinois' physical upset of USC, and Indiana's continued rise behind quarterback Fernando Mendoza. Plus, Ohio State shook off a slow start to beat Washington, while Minnesota and Rutgers battled to the final kick. We also look at Northwestern's surprising win over UCLA and how the AP Top 25 stacks up heading into Week 6. With Michigan–Wisconsin looming and key matchups across the league, this episode delivers insights you won't want to miss.This episode is sponsored in part by TicketSmarter:Use promo code LWOS10 to receive $10 off purchases of $100 or moreUse promo code LWOS20 to receive $20 off purchases of $300 or moreThink smarter.  TicketSmarter

Derek returns to help Ryan and Luke break down the Gophers first B1G victory of the season.

The Minnesota Gophers are 1-0 in Big Ten conference play after a nail-biting 31-28 victory over Rutgers. What a day for Minnesota Gophers Quarterback Drake Lindsey who passed all over Rutgers as he threw for 324 yards in the Minnesota Gophers victory. The Minnesota Gophers did struggle to run the ball and stop the run. How concerned should Minnesota Gophers fans be as the Gophers prepare for Ohio State next weekend?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Minnesota - Rutgers Scene Setter with Mike Grimm!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Minnesota Gophers are 1-0 in Big Ten conference play after a nail-biting 31-28 victory over Rutgers. What a day for Minnesota Gophers Quarterback Drake Lindsey who passed all over Rutgers as he threw for 324 yards in the Minnesota Gophers victory. The Minnesota Gophers did struggle to run the ball and stop the run. How concerned should Minnesota Gophers fans be as the Gophers prepare for Ohio State next weekend?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mike, Larry K, Craig and Alec all join together to discuss Rutgers' heartbreaking 31-28 loss at Minnesota in this live postgame show Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

@BettorEdge Partner Promo Code: PLAYME Signup Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bettoredge.com/playme⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Peer to peer sports betting with NO JUICE! Click the link for a risk free $20, no deposit required. Join the Free Discord + View Our Podcast Record⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://discord.gg/eudQA8B3⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Podcast Card: Arkansas State ML at UL Monroe (+150)LSU ML at Ole Miss (+113)Jacksonville State ML at Southern Miss (+158)San Jose State ML at Stanford (+112)Oregon ML at Penn State (+142)Alabama ML at Georgia (+134)Marshall ML at Louisiana (+121)Eastern Michigan ML at Central Michigan (+147)Rice +14 at Navy (+100)Eastern Michigan +3.5 at Central Michigan (+100)Bowling Green +7.5 at Ohio (+101)Wake Forest +14 vs. Georgia Tech (+100)Illinois +7 vs. USC (-105)Notre Dame -4.5 at Arkansas (+102)Minnesota -5 vs. Rutgers (-100)Syracuse/Duke Under 59.5 (-103)Pittsburgh +3.5 vs. Louisville (+100)Kansas State -5.5 vs. UCF (+100)Utah State +23.5 at Vanderbilt (+100)Ohio State -8.5 at Washington (-100)Iowa +8.5 vs. Indiana (-104)Boston College -6.5 vs. California (+100)Air Force -6.5 vs. Hawaii (-103)Florida Atlantic +14 vs. Memphis (+101)South Carolina -5.5 vs. Kentucky (-100) Texas Rangers +1.5 at Cleveland Guardians (-158)Arizona Diamondbacks +1.5 at San Diego Padres (-170)Seattle Mariners +1.5 vs. LA Dodgers (-190)New York Yankees ML vs. Baltimore Orioles (-211)Toronto Blue Jays ML vs. Tampa Bay Rays (-146)New York Mets ML at Miami Marlins (-114)Cincinnati Reds ML at Milwaukee Brewers (+137)Houston Astros ML at LA Angels (line TBD)Detroit Tigers ML at Boston Red Sox (line TBD) YouTube Link:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.youtube.com/@PlayMeorFadeMePodcast?sub_confirmation=1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

The Scarlet Knights let a golden opportunity slip through after jumping all over the Gophers at the start of the game. Two missed field goals and a big kickoff allowed, continued defensive struggles and a lack of second half execution by the offense let to the disappointing defeat.#rutgersfootball

This week is United Nations Climate Week in New York City. During his address to the U.N., Trump talked about the climate crisis being a hoax and how "the environmentalists want to kill all the cow."To discuss the climate crisis with a lens of resistance and militancy, Scott talks with Prof. John Maerhofer, lecturer at Rutgers, and author of "Guerrilla Ecologies: Green Capital, Nature, and the Politics of Catastrophe" about capital's attack on the environment and radical militant responses to it. They discuss the legacy of Rachel Carson and the mainstreaming of the U.S. environmental movement, the rise of green capitalism, liberal co-optation of the environmental movement, and militant eco-movements in the U.S. and around the world. Bio//John Maerhofer, Ph.D. is an activist-scholar based in the greater NYC area. He has taught literature, radical ecological history, and interdisciplinary studies at various colleges and universities, including Hofstra University, the University of Rhode Island, and at several campuses in the CUNY system. He is currently a full-time Teaching Instructor at Rutgers University where he teaches in the Writing Program. He is author of Guerrilla Ecologies:Green Capital, Nature, and the Politics of Catastrophe.-------------------------------Outro- "Green and Red Blues" by Moody

Chad Greenway joins the show to talk about international games in the NFL and preview the Vikings game vs the Steelers. Then Mike Grimm joins and show and talks about the Gophers upcoming game vs Rutgers.

Chad Greenway joins the show to talk about international games in the NFL and preview the Vikings game vs the Steelers. Then Mike Grimm joins and show and talks about the Gophers upcoming game vs Rutgers.See omnystudio.com/listener for privacy information.

The Knight Report Podcast is back, as Richie O'Leary and Alec Crouthamel discuss the recent commitment of Imahri Wooten for Rutgers Basketball, analyzing his skills (02:47) and how he ended up in the Scarlet Knights class (5:49). After that, the guys delve into the recruitment process, the challenges faced by the coaching staff, and the future of the 2026 recruiting class (8:18). Additionally, they explore the concept of a rivalry trophy for Maryland and Rutgers, offering their thoughts on the trophy (19:44) JOIN The Knight Report: tinyurl.com/TKRpromo FOLLOW us on Twitter: https://twitter.com/RutgersOn3 FOLLOW us on Instagram: https://www.instagram.com/RutgersOn3 LIKE our Facebook Page: https://www.facebook.com/TheKnightReport Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Minnesota Gophers will take on Athan Kaliakmanis and Rutgers this Saturday at Huntington Bank Stadium. Is this a stereotypical revenge game for the Minnesota Gophers when they take on Athan Kaliakmanis and Rutgers? How important is this weekend's game for the Minnesota Gophers and what do the Minnesota Gophers need to do to ensure a victory over Rutgers to start the Big Ten season off strong? Ross Brendel and Thor Nystrom also take a quick look around college football and Thor gives us this weeks “Thorfer” where he highlights a former Minnesota Gopher in the pros! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Constitution Study with Host Paul Engel – Based on a Rutgers poll, more than half of people who identify as “left” believe assassinating a sitting president may be justified. To some, even a simple murder is terrorism. And yes, this is sick. Then we have the examples of federal actors ignoring the Constitution, like Congress's deficit spending, the DOJ's illegal demand for state voter registration data, while...

There are certain Saturdays that feel like they were built for college football: the lights, the noise, the choreography of a crowd that feels like it's part of the playbook. This week's conversation at Y-Option, presented by 76–keeping you on the GO GO GO so you never miss a beat, welcomes back Todd Blackledge. On Saturday night, Todd will have the best seat in the house as he broadcasts the Oregon v Penn State game in Happy Valley during the Nittany Lions annual White Out.We dive into what it is like to broadcast a White Out, the match-ups he is looking forward to seeing play out and analyze both Drew Allar and Dante Moore.Todd shared the origin of his own career and how there is a unique connection between the start of his illustrious career and the famed White Out. He also shared how he prepares for a game like this, as he has known for months that NBC and his crew would be on the call.He also shared his truth on what Drew Allar needs to do in this environment and what this top 6 match-up will come down to.I've known Todd since he was calling Big East games back when I was playing and he's been a constant source of inspiration and support since we met in the early 2000s. Be sure to tune into the White Out this Saturday night as this rematch of the Big Ten Championship game from last season may be a classic. And to both fan bases, win or lose, your season is neither complete or ruined. Yes, it's a massive data point but it's only week 5, and we have a lot of ball left to play.I'm off to Minnesota to call one of the most intriguing games of the weekend as Rutgers and Greg Schiano visit P.J. Fleck, who once worked on Schiano's staff. I have a feeling we will kick off your Saturday with a four quarter game that will come down to a few plays, a few decisions.Enjoy Week 5 and as always, much love and stay steady,YogiY-Option: College Football with Yogi Roth is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.y-option.com/subscribe

The Rutgers Rant is back to predict the Scarlet Knights' first road game of the season at Minnesota. Read our reporting at NJ.com/Rutgers, join our Discord community (discord.gg/fbVDPPA3uW) to interact with us and other Scarlet Knight fans and follow us on Twitter (@RutgersRant) for the latest updates on the show. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Minnesota Gophers will take on Athan Kaliakmanis and Rutgers this Saturday at Huntington Bank Stadium. Is this a stereotypical revenge game for the Minnesota Gophers when they take on Athan Kaliakmanis and Rutgers? How important is this weekend's game for the Minnesota Gophers and what do the Minnesota Gophers need to do to ensure a victory over Rutgers to start the Big Ten season off strong? Ross Brendel and Thor Nystrom also take a quick look around college football and Thor gives us this weeks “Thorfer” where he highlights a former Minnesota Gopher in the pros! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Luke and Ryan preview the first home game for that Gophers as they host the Scarlet Knights. 

Chad Leistikow and Scott Dochterman look back on Iowa's win over Rutgers and how Gronowski proved himself. Has Tim Lester found his groove? Diving into Indiana and the tall task ahead for the Hawkeyes. Bouncing around the Big Ten and more, courtesy of GameDay Men's Health. Learn more about your ad choices. Visit megaphone.fm/adchoices

2 hour and 26 minutes The Sponsors Thank you to Underground Printing for making this all possible. Rishi and Ryan have been our biggest supporters from the beginning. Check out their wide selection of officially licensed Michigan fan gear at their 3 store locations in Ann Arbor or learn about their custom apparel business at undergroundshirts.com. Our associate sponsors are: Peak Wealth Management, Matt Demorest - Realtor and Lender, Ann Arbor Elder Law, Michigan Law Grad, Human Element, Sharon's Heating & Air Conditioning, The Sklars Brothers, Champions Circle, Winewood Organics, Community Pest Solutions, Venue by 4M where record this, and Introducing this season: Radecki Oral Surgery, and Long Road Distillers. 1. Offense vs Nebraska Starts at 1:00 Is yogurt, honey, and granola a snack? Dave Nastersnacks will give us the answer. Oklahoma was a 24-13 loss but it felt worst than that, this was 30-27 win but it felt better than that (but also worse!). The domination on both lines was more notable than some of the silly, bad things that happened. Between Oklahoma and Nebraska, Michigan hasn't had a complete touchdown drive (but this game had an 8 minute drive to go up by 10). Caveats aside, we're on the verge of saying Greg Crippen is good after he blocked three guys on one play. Running stretch is hard and they're running it quite well. McCulley had a great game but was to blame on Semaj's throw being incomplete. Zero drops otherwise and ran guys over. Everyone else? Not so great. Gotta catch the ball on a slant, get used to passes from Underwood. Should they throw it to Peyton O'Leary? The running backs sure toughened up in this one. Max Bredeson blocks everyone like they're Caleb Downs in the Rose Bowl. Not many Bryce critiques. Catch the ball. Guarnera is just not making mistakes. What's the next good defensive line that Michigan will play, Ohio State? Michigan consistently got a play in, saw the look of the defense, and got a new play in.  2. Defense vs Nebraska Starts at 46:58 Time for a Wink Martindale argument? He doesn't need to do anything fancy. Just run the Iowa defense, you're not going up against an NFL offense. Brandyn Hillman is being asked to do things outside of his base job. 27 points, seven are on Biff, seven are on Hillman taunting, three are on Mangham missing a sack. Otherwise it was pretty good? Raiola was getting sacked every other play. Too many safeties missing sacks. Complaining aside, they got to the quarterback a lot and tackled well. Sanders has been playing a lot and there haven't really been any negative feelings about him. Wink would be a better poker player than Mike Debord but not as good as Jesse Minter. This game felt like Trey Pierce arrived. Cole Sullivan has absolutely emerged, he's little bit of everywhere and has freaky long arms. Defensive backs played well. The Shamari Earls PI was a bit weak. Brandyn Hillman needs to grow up, that was the most obvious personal foul in a minute. Brian usually defends players celebrating and even he says that's an obvious foul. Was it a targeting call at the end of the game? Let's talk about the Hail Mary. Why was TJ Guy dropping? Why was there a spy?  3. Hot Takes, Game Theory, and Special Teams Starts at 1:25:17 Takes hotter than a Wisconsin fan looking at whatever the shit that was on Saturday. If you're Nebraska, would you go for it on 4th and 2 on the opening drive? Should Michigan have called timeout at the end of the first half? Maybe Sherrone could make a better call here but we can't know that. Zvada hit a 56 yarder and a chip shot to seal it, yay. Punting was okay, how do you recruit punters? What's with Semaj at punt returns? Punt returning has been a problem for a couple years now. Kendrick Bell got the onside! Gary Danielson and Brad Nessler are washed. The turf was a little slippy?  4. Around the Big Ten with Jamie Mac Starts at 1:51:48 Indiana 63, Illinois 10 This is the most points a top 10 team has been beaten by. This looks like Michigan's boxscore against Central. Cignetti is vindicated. How much is this Indiana being legit and Illinois never being top 10 team? Maryland 27, Wisconsin 10 The boxscore shows a relatively even game, BUT Maryland blocks a punt, field goal, and gets one of the easiest interceptions you've seen. Luke Fickell is done. The boo birds were just apathetic, which is worse than booing. 61 rush yards for Wisconsin on 42 attempts.  Oregon 41, Oregon State 7 Oregon State has fallen on hard times since college football ejected them. This game looked like a controlled scrimmage. Is Oregon really good or just beating up on bad teams? We'll see how Oregon does during a whiteout at Penn State next weekend.  Notre Dame 56, Purdue 30 Purdue's defense is really bad. Purdue is Purdue.  Iowa 38, Rutgers 28 Iowa returns the opening kickoff for a touchdown and could not stop Rutgers' QB. Both teams went up and down the field, what is happening??  USC 45, Michigan State 31 The boxscore looks a little close but MSU gets a 75 yard drive down three touchdowns. Mostly a blowout. The Spartans' defense did not have answers to USC's running game. Aidan Chiles had some explosive plays.  Washington 59, Washington State 24 Another Pacific Northwest rivalry that college football has ruined. Does Washington have the best complete package for skill position players in the conference? We don't trust Ohio State's run game.  MUSIC: "Wave Goodnight"—Jeff Rosenstock "Alien With a Sleep Mask"—Batboys "Big Dipper"—Built to Spill “Across 110th Street”—JJ Johnson and his Orchestra